The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance
Top Cited Papers
Open Access
- 1 November 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (44) , 41245-41254
- https://doi.org/10.1074/jbc.m103241200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Unraveling the mechanism of action of thiazolidinedionesJournal of Clinical Investigation, 2000
- Cellular mechanisms of insulin resistanceJournal of Clinical Investigation, 2000
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 1999
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.Journal of Clinical Investigation, 1998
- Functional Antagonism between CCAAT/Enhancer Binding Protein-α and Peroxisome Proliferator-activated Receptor-γ on the Leptin PromoterPublished by Elsevier ,1997
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Adipose tissue cellularity and lipolysis. Response to exercise and cortisol treatment.Journal of Clinical Investigation, 1975